Skip to main content

Amryt Pharma PLC (AMYT)

NASDAQ: AMYT · IEX Real-Time Price · USD
10.59 -0.55 (-4.94%)
Oct 25, 2021 4:00 PM EDT - Market closed

Total Valuation

Amryt Pharma has a market cap or net worth of $685.51 million. The enterprise value is $736.21 million.

Market Cap685.51M
Enterprise Value736.21M

Important Dates

The next earnings date is Thursday, November 4, 2021 before market open.

Estimated Earnings DateNov 4, 2021
Ex-Dividend Daten/a

Share Statistics

Amryt Pharma has 63.38 million shares outstanding. The number of shares has increased by 4.48% in one year.

Shares Outstanding63.38M
Shares Change (YoY)+4.48%
Shares Change (QoQ)+0.33%
Owned by Insiders (%)n/a
Owned by Institutions (%)24.76%
Float20.63M

Valuation Ratios

PE Ration/a
Forward PE12.87
PS Ratio3.38
PB Ratio13.90
P/FCF Ratio14.75
PEG Ration/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of 15.84.

EV / Earningsn/a
EV / Sales3.63
EV / EBITDAn/a
EV / EBITn/a
EV / FCF15.84

Financial Position

The company has a current ratio of 2.19, with a Debt / Equity ratio of 3.93.

Current Ratio2.19
Quick Ratio1.81
Debt / Equity3.93
Debt / EBITDA-14.49
Debt / FCF4.17

Financial Efficiency

Return on Equity (ROE)-132.20%
Return on Assets (ROA)-15.40%
Return on Capital (ROIC)-31.90%
Revenue Per Employee$1.12M
Profits Per Employee-$443,940
Employee Count182
Asset Turnover0.39
Inventory Turnover3.42

Taxes

In the past 12 months, Amryt Pharma has paid $4.46 million in taxes.

Income Tax4.46M
Effective Tax Rate-5.84%

Stock Price Statistics

The stock price has decreased by -12.75% in the last 52 weeks. The beta is 0.11, so Amryt Pharma's price volatility has been lower than the market average.

Beta (1Y)0.11
52-Week Price Change-12.75%
50-Day Moving Average11.67
200-Day Moving Average11.76
Average Volume (30 Days)81,104

Short Selling Information

Short Interest318,664
Short % of Shares Out0.50%
Short % of Float1.54%
Short Ratio (days to cover)4.08

Income Statement

In the last 12 months, Amryt Pharma had revenue of $203.04 million and -$80.80 million in losses. Earnings per share was -$2.39.

Revenue203.04M
Gross Profit96.44M
Operating Income-16.83M
Pretax Income-76.34M
Net Income-80.80M
EBITDA-13.36M
EBIT-57.16M
Earnings Per Share (EPS)-$2.39
Full Income Statement

Balance Sheet

The company has $142.95 million in cash and $193.65 million in debt, giving a net cash position of -$50.70 million or -$0.80 per share.

Cash & Cash Equivalents142.95M
Total Debt193.65M
Net Cash-50.70M
Net Cash Per Share-$0.80
Book Value49.31M
Book Value Per Share0.78
Working Capital121.39M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $49.65 million and capital expenditures -$3.19 million, giving a free cash flow of $46.47 million.

Operating Cash Flow49.65M
Capital Expenditures-3.19M
Free Cash Flow46.47M
FCF Per Share$0.73
Full Cash Flow Statement

Margins

Gross margin is 47.50%, with operating and profit margins of -8.29% and -39.79%.

Gross Margin47.50%
Operating Margin-8.29%
Pretax Margin-37.60%
Profit Margin-39.79%
EBITDA Margin-6.58%
EBIT Margin-28.15%
FCF Margin22.89%

Dividends & Yields

Amryt Pharma does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-11.79%
FCF Yield6.78%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a